"Hi XXXXX.

Thanks for your recent thoughts and analyses.

Recently I have had a look at the posts on the BB's and notice that the opinions are generally positive about the proposed acquisition. However, I do see some rather uninformed commentary, as usual.

Here are some ideas which anyone could figure out if they put a bit of thought into it.

Why would we pay $6 Million and 2 million shares? The news release states that the company has products, customers and revenues. Maybe we think it's worth it.

How are we going to pay $6 million when we have closer to $2 Million in the bank? Debt or equity or some combination are the ways to raise money.


Will we sell 40 million shares? Why would we do that now when we have 6 months to close the deal.

If the China news release is reviewed, anyone will see that He-Yi has the agreements for $2 Million in sales, not ALDA. ALDA gets a royalty.

The agreement is non-binding because a number of conditions need to be satisfied. Reading the news release clarifies those conditions. The company is obliged by securities laws to disclose the Letter of Intent.

A Norwalk like, virus, as explained in the news release, is a surrogate that is close to virus of interest. Norwalk is difficult to reproduce in cell culture, so Feline Calicivirus is an FDAapproved surrogate.

Cheers,

Terry"